• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9549
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation of Vessels (2135); Cardiogenic Shock (2262); Pericardial Effusion (3271); Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/20/2023
Event Type  Death  
Manufacturer Narrative
E1 initial reporter address: (b)(6).
 
Event Description
It was reported that a perforation and pericardial effusion occurred and the patient died.The patient presented with the left main (lm) to left anterior descending (lad) arteries and left circumflex (lcx) artery diffusely and severely diseased.Poor left ventricular function was also noted.The distal lm to lad lesion was 70% stenosed and highly calcified.The ostial lcx lesion was 80% stenosed.Severely calcified and tortuous.The lad was stented with a 2.75 mm x 38 mm promus premier and 3.50 mm x 24 mm promus premier.A 2.75 mm x 16 mm promus premier was deployed in the lcx.Intravascular ultrasound was performed using an opticross catheter.During post-dilation in the lad, a perforation and pericardial effusion occurred.The physician inflated a balloon at the site of the pericardial effusion in an attempt to arrest the flow, but was unsuccessful.The physician decided that coronary artery bypass surgery (cabg) was necessary.Before the cabg procedure, the patient became hemodynamically unstable and expired.The official cause of death was cardiogenic shock.
 
Manufacturer Narrative
E1 initial reporter address: (b)(6).
 
Event Description
It was reported that a perforation and pericardial effusion occurred and the patient died.The patient presented with the left main (lm) to left anterior descending (lad) arteries and left circumflex (lcx) artery diffusely and severely diseased.Poor left ventricular function was also noted.The distal lm to lad lesion was 70% stenosed and highly calcified.The ostial lcx lesion was 80% stenosed.Severely calcified and tortuous.The lad was stented with a 2.75 mm x 38 mm promus premier and 3.50 mm x 24 mm promus premier.A 2.75 mm x 16 mm promus premier was deployed in the lcx.Intravascular ultrasound was performed using an opticross catheter.During post-dilation in the lad, a perforation and pericardial effusion occurred.The physician inflated a balloon at the site of the pericardial effusion in an attempt to arrest the flow, but was unsuccessful.The physician decided that coronary artery bypass surgery (cabg) was necessary.Before the cabg procedure, the patient became hemodynamically unstable and expired.The official cause of death was cardiogenic shock.Upon further review by a medical professional, it was determined that the 2.75 mm x 16 mm promus premier deployed in the lcx and opticross catheter could not have caused or contributed to the lad perforation, pericardial effusion and subsequent death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18257940
MDR Text Key329621487
Report Number2124215-2023-67744
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/04/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9549
Device Catalogue Number9549
Device Lot Number0030734260
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/06/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age70 YR
Patient SexMale
Patient RaceAsian
-
-